Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Chronic Lymphocytic Leukemia (CLL)
Join Jennifer Brown, MD, PhD, and Matthew Davids, MD, MMSc, from Dana-Farber Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to chronic lymphocytic leukemia (CLL).
Category
  • Chronic Lymphocytic Leukemia
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Updates in the Management of CLL: Histologic Transformation and Relapsed/Refractory Disease
Histologic transformation of chronic lymphocytic leukemia (CLL) to more aggressive lymphoma is associated with a poor prognosis since it is typically resistant to standard chemoimmunotherapy regimens used for the treatment of CLL.
Category
  • Chronic Lymphocytic Leukemia
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation